Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ruggenenti

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of the American Society of Nephrology : JASN|December 10, 1999
Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG)G Remuzzi, J Grinyò, P Ruggenenti, et al.
Transplantation|July 1, 1992
Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantationN Perico, P Ruggenenti, F Gaspari, et al.
Kidney International|March 1, 1993
Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusionP Ruggenenti, N Perico, L Mosconi, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1992
Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of Haemolytic Uremic SyndromeA Schieppati, P Ruggenenti, R P Cornejo, et al.
Journal of the American Society of Nephrology : JASN|August 1, 1995
Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rateF Gaspari, N Perico, P Ruggenenti, et al.
Kidney International|April 1, 1992
Measurement of GFR with a single intravenous injection of nonradioactive iothalamateF Gaspari, L Mosconi, G Viganò, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1996
Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injuryM Noris, P Ruggenenti, M Todeschini, et al.
Kidney International|October 24, 2000
Pretreatment blood pressure reliably predicts progression of chronic nephropathies. GISEN GroupP Ruggenenti, A Perna, M Lesti, et al.
Lancet (London, England)|August 7, 1999
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaP Ruggenenti, A Perna, G Gherardi, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic PurpuraM Noris, P Ruggenenti, A Perna, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of the American Society of Nephrology : JASN|December 10, 1999
Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG)G Remuzzi, J Grinyò, P Ruggenenti, et al.
Transplantation|July 1, 1992
Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantationN Perico, P Ruggenenti, F Gaspari, et al.
Kidney International|March 1, 1993
Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusionP Ruggenenti, N Perico, L Mosconi, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1992
Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of Haemolytic Uremic SyndromeA Schieppati, P Ruggenenti, R P Cornejo, et al.
Journal of the American Society of Nephrology : JASN|August 1, 1995
Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rateF Gaspari, N Perico, P Ruggenenti, et al.
Kidney International|April 1, 1992
Measurement of GFR with a single intravenous injection of nonradioactive iothalamateF Gaspari, L Mosconi, G Viganò, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1996
Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injuryM Noris, P Ruggenenti, M Todeschini, et al.
Kidney International|October 24, 2000
Pretreatment blood pressure reliably predicts progression of chronic nephropathies. GISEN GroupP Ruggenenti, A Perna, M Lesti, et al.
Lancet (London, England)|August 7, 1999
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaP Ruggenenti, A Perna, G Gherardi, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic PurpuraM Noris, P Ruggenenti, A Perna, et al.
Pageof 10